0
Article ? AI-assigned paper type based on the abstract. Classification may not be perfect — flag errors using the feedback button. Tier 2 ? Original research — experimental, observational, or case-control study. Direct primary evidence. Human Health Effects Nanoplastics Sign in to save

Estrogenic activity of plastic nanoparticle mixtures under in vitro settings

Environmental Science Nano 2024 1 citation ? Citation count from OpenAlex, updated daily. May differ slightly from the publisher's own count. Score: 45 ? 0–100 AI score estimating relevance to the microplastics field. Papers below 30 are filtered from public browse.
Lucija Božičević, Korinna Altmann, Jana Hildebrandt, Xenia Knigge, Valerije Vrček, Nikolina Peranić, Nikolina Kalčec, Nikolina Kalčec, Ivana Vinković Vrček

Summary

This study investigated the endocrine disrupting effects of polyethylene, polystyrene, and polypropylene nanoparticles individually and in mixtures under in vitro conditions. Results provided science-based evidence of estrogenic activity from all three nanoparticle types, emphasizing the importance of assessing aggregate exposure to nanoplastic mixtures rather than individual polymers.

Body Systems
Study Type In vitro

This study provides science-based evidence on endocrine disrupting effects of polyethylene, polystyrene and polypropylene nanoparticles and their mixtures indicating the importance of hazard assessment of aggregate exposure to nanoplastics.

Sign in to start a discussion.

More Papers Like This

Article Tier 2

Nanoplastics increase in vitro oestrogenic activity of neurotherapeutic drugs

Researchers found that polystyrene nanoplastics significantly enhance the estrogenic activity of neurotherapeutic drugs in vitro, suggesting that nanoplastic contamination of drinking water and food could increase hormonal exposures from pharmaceutical residues.

Article Tier 2

Endocrine Disrupting Activity of Mixtures Composed of Pharmaceuticals and Nanoplastics

This study investigated the combined endocrine-disrupting activity of pharmaceutical compounds mixed with nanoplastics, examining how the mixture behaves differently from individual components. Nanoplastics can adsorb and concentrate endocrine-disrupting chemicals from the environment, potentially delivering combined hormonal effects to organisms that ingest them.

Article Tier 2

Silver and polystyrene nanoparticles activate oestrogen signalling via cytoplasmic oestrogen receptor

This study found that both nanoplastic polystyrene particles and silver nanoparticles (AgNPs) activate estrogen signaling in breast cancer cells by binding to cytoplasmic estrogen receptors. The results suggest these two common nanomaterials are endocrine disruptors capable of mimicking estrogenic activity, with potential implications for hormone-driven diseases.

Article Tier 2

Single and joint exposure to nanoplastics and bisphenols: a comparative assessment of in vitro hazards

This study compared the individual and combined toxicity of nanoplastics and bisphenol compounds in biological test systems, finding synergistic effects at certain exposure combinations. The results indicate that co-exposure to these two common plastic-associated contaminants may be more harmful than either alone.

Article Tier 2

Effects of polystyrene micro- and nanoplastics on androgen- and estrogen receptor activity and steroidogenesis in vitro

Researchers tested how polystyrene micro and nanoplastics of various sizes affect hormone receptor activity and steroid hormone production in human cells grown in the lab. Smaller nanoplastics (50-1000 nm) were taken up into cells and interfered with both estrogen and androgen receptor signaling, while also altering the production of key hormones. This study provides direct evidence that nanoplastics can disrupt the human endocrine system at the cellular level, which could have implications for reproductive health.

Share this paper